Broker Recommendations

Berenberg starts Genus at 'buy', cites protein demand and China opportunity

By Iain Gilbert

Date: Wednesday 26 Nov 2025

(Sharecast News) - Analysts at Berenberg initiated coverage on genetics firm Genus with a 'buy' rating and a 3,050p target price on Wednesday, stating the "long-term underlying dynamics" of the business "look attractive".
Berenberg said the combination of rising population growth and increasing urbanisation, most notably in developing markets, had created...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page